News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
653,378 Results
Type
Article (23005)
Company Profile (212)
Press Release (630151)
Multimedia
Podcasts (77)
Webinars (19)
Section
Business (216023)
Career Advice (775)
Deals (32690)
Drug Delivery (66)
Drug Development (66739)
Employer Resources (63)
FDA (14164)
Job Trends (12220)
News (307725)
Policy (24480)
Tag
2027 BioCapital Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (4)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (3)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (5)
Academia (1681)
Accelerated approval (62)
ADA (27)
Adcomms (13)
Allergies (168)
Alliances (48417)
ALS (189)
Alzheimer's disease (1546)
Antibody-drug conjugate (ADC) (473)
Approvals (14772)
Artificial intelligence (799)
ASCO (222)
Autoimmune disease (303)
Automation (68)
Bankruptcy (300)
Best Places to Work (9752)
BIO (65)
BIOSECURE Act (8)
Biosimilars (153)
BioSpace Insights (109)
Biotechnology (144)
Bladder cancer (177)
Brain cancer (65)
Breast cancer (674)
Cancer (5427)
Cardiovascular disease (355)
Career advice (677)
Career pathing (18)
CAR-T (327)
CDC (15)
Celiac Disease (1)
Cell therapy (883)
Cervical cancer (50)
Clinical research (59224)
Collaboration (2263)
Commercialization (4)
Company closure (1)
Compensation (1522)
Complete response letters (53)
COVID-19 (1683)
CRISPR (122)
C-suite (1197)
Cystic fibrosis (122)
Data (7537)
Decentralized trials (3)
Denatured (31)
Depression (133)
Dermatology (81)
Diabetes (494)
Diagnostics (6716)
Digital health (68)
Diversity (8)
Diversity, equity & inclusion (14)
Drug discovery (371)
Drug pricing (42)
Drug shortages (9)
Duchenne muscular dystrophy (271)
Earnings (85914)
Editorial (23)
Employer branding (9)
Employer resources (60)
Events (110364)
Executive appointments (1091)
FDA (17961)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (20)
Frontotemporal dementia (30)
Funding (1766)
Gene editing (257)
Generative AI (70)
Gene therapy (691)
GLP-1 (567)
Government (2256)
Grass and pollen (5)
Guidances (378)
Healthcare (15044)
Hematology (148)
HIV (81)
Huntington's disease (54)
IgA nephropathy (100)
Immunology and inflammation (164)
Immuno-oncology (79)
Indications (206)
Infectious disease (1991)
Inflammatory bowel disease (174)
Inflation Reduction Act (7)
Influenza (132)
Intellectual property (316)
Interviews (97)
IPO (15266)
IRA (12)
Job creations (2860)
Job search strategy (597)
JPM (35)
Kidney cancer (19)
Labor market (34)
Layoffs (229)
Leadership (15)
Legal (6111)
Licensing (9)
Liver cancer (77)
Longevity (30)
Lung cancer (693)
Lymphoma (410)
Machine learning (61)
Management (24)
Manufacturing (1045)
Marketing (10)
MASH (163)
Medical device (13854)
Medtech (14087)
Mergers & acquisitions (18781)
Metabolic disorders (1054)
mRNA (220)
Multiple sclerosis (145)
NASH (11)
Neurodegenerative disease (397)
Neuropsychiatric disorders (60)
Neuroscience (2885)
NextGen: Class of 2026 (5201)
Non-profit (2559)
Now hiring (23)
Obesity (362)
Opinion (174)
Ovarian cancer (209)
Pain (229)
Pancreatic cancer (294)
Parkinson's disease (326)
Partnered (33)
Patents (615)
Patient recruitment (727)
Peanut (63)
People (54658)
Pharmaceutical (42)
Pharmacy benefit managers (12)
Phase 1 (19513)
Phase 2 (26336)
Phase 3 (18176)
Pipeline (9892)
Policy (124)
Postmarket research (1784)
Preclinical (8335)
Press Release (70)
Prostate cancer (282)
Psychedelics (23)
Radiopharmaceuticals (324)
Rare diseases (940)
Real estate (5043)
Recruiting (27)
Regulatory (20921)
Reports (32)
Research institute (1811)
Resumes & cover letters (120)
Rett syndrome (48)
RNA editing (23)
RSV (69)
Schizophrenia (129)
Series A (302)
Series B (225)
Service/supplier (7)
Sickle cell disease (86)
Special edition (8)
Spinal muscular atrophy (110)
Sponsored (30)
Startups (3439)
State (2)
Stomach cancer (8)
Supply chain (90)
Tariffs (22)
The Weekly (44)
Vaccines (772)
Venture capital (85)
Weight loss (156)
Women's health (110)
Worklife (4)
Date
Today (29)
Last 7 days (575)
Last 30 days (2132)
Last 365 days (26712)
2026 (17175)
2025 (26614)
2024 (31287)
2023 (35970)
2022 (46441)
2021 (50144)
2020 (47188)
2019 (37718)
2018 (28304)
2017 (28006)
2016 (26952)
2015 (33345)
2014 (28192)
2013 (24053)
2012 (26035)
2011 (26326)
2010 (25122)
Location
Africa (478)
Alabama (89)
Alaska (6)
Arizona (365)
Arkansas (16)
Asia (34976)
Australia (5462)
California (13882)
Canada (3791)
China (1257)
Colorado (603)
Connecticut (580)
Delaware (337)
Europe (67856)
Florida (2083)
Georgia (446)
Hawaii (4)
Idaho (63)
Illinois (1065)
India (90)
Indiana (480)
Iowa (21)
Japan (602)
Kansas (132)
Kentucky (46)
Louisiana (44)
Maine (42)
Maryland (1602)
Massachusetts (9909)
Michigan (403)
Minnesota (785)
Mississippi (6)
Missouri (149)
Montana (33)
Nebraska (21)
Nevada (131)
New Hampshire (89)
New Jersey (3294)
New Mexico (29)
New York (3640)
North Carolina (1730)
North Dakota (10)
Northern California (6914)
Ohio (414)
Oklahoma (26)
Oregon (29)
Pennsylvania (2669)
Puerto Rico (26)
Rhode Island (50)
South America (764)
South Carolina (90)
South Dakota (1)
Southern California (5679)
Tennessee (211)
Texas (2274)
United States (48195)
Utah (435)
Vermont (2)
Virginia (271)
Washington D.C. (57)
Washington State (1131)
West Virginia (3)
Wisconsin (147)
Wyoming (1)
653,378 Results for "accelerated technologies inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Approvals
Vera moves into growing kidney disease space with FDA’s accelerated IgAN nod
Vera Therapeutics’ atacicept, to be marketed as Trutakna, will go up against Novartis, Otsuka and possibly Vertex in the kidney disease primary IgA nephropathy after receiving an accelerated FDA approval.
July 7, 2026
·
2 min read
·
Annalee Armstrong
Press Releases
Spectrum Vascular Acquires Piccolo Medical, Accelerating Launch of Next-Generation Catheter Navigation Technology
June 11, 2026
·
3 min read
Press Releases
Median Technologies Reports Record iCRO Backlog, Accelerates Commercial Rollout of eyonis® LCS and Development of New Indications Across the eyonis® Portfolio
July 23, 2026
·
9 min read
Press Releases
Insulet Accelerates Global Growth with Launch of Omnipod® 5 and Omnipod Discover™ in Spain, Expanding Access to Tubeless Diabetes Technology
July 6, 2026
·
6 min read
Press Releases
Atrandi Biosciences Expands Leadership Team to Accelerate Global Adoption of Capsule-Based Single-Cell Technology
May 19, 2026
·
4 min read
Press Releases
Collegium Announces $50 Million Accelerated Share Repurchase Program
August 13, 2026
·
5 min read
Press Releases
Full-Life Technologies Announces US$150 Million Financing to Accelerate Multiple Clinical Stage Assets and Manufacturing Capabilities
May 19, 2026
·
3 min read
FDA
Drug pricing watchdog calls for increased transparency into FDA’s accelerated approval decisions
Greater transparency in FDA decision-making was possibly the most common theme for stakeholders interviewed by the Institute for Clinical and Economic Review in a new report focused on strengthening the agency’s accelerated approval program.
April 16, 2026
·
4 min read
·
Heather McKenzie
Huntington’s disease
Novartis, PTC push Huntington’s drug into Phase 3, mum on accelerated approval
Phase 2 data from PTC Therapeutics showed that the Novartis-partnered Huntington’s disease asset slowed progression by more than 50%. Analysts say the decision to initiate a last-stage trial reflects a lack of confidence in an accelerated FDA nod.
April 29, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Alnylam and Inceptive Form Strategic AI Collaboration to Accelerate the Discovery of RNAi Therapeutics
June 4, 2026
·
7 min read
1 of 65,338
Next
